Bank of New York Mellon’s Sanara MedTech SMTI Stock Holding History

Bank of New York Mellon’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,038	Closed	-$414K	–	4277
2025 Q3	$414K	Sell	13,038 -650	-5%	-$19.6K	﹤0.01%	3701
2025 Q2	$389K	Sell	13,688 -192	-1%	-$5.76K	﹤0.01%	3651
2025 Q1	$428K	Buy	13,880 +826	+6%	+$28K	﹤0.01%	3525
2024 Q4	$433K	Buy	13,054 +2,528	+24%	+$85.7K	﹤0.01%	3598
2024 Q3	$318K	Sell	10,526 -2,781	-21%	-$86.7K	﹤0.01%	3733
2024 Q2	$376K	Buy	13,307 +230	+2%	+$7.22K	﹤0.01%	3713
2024 Q1	$484K	Sell	13,077 -1,093	-8%	-$40.9K	﹤0.01%	3542
2023 Q4	$582K	Buy	14,170 +3,741	+36%	+$120K	﹤0.01%	3470
2023 Q3	$325K	Hold	10,429	–	–	﹤0.01%	3770
2023 Q2	$418K	Buy	+10,429	New	+$427K	﹤0.01%	3691

Other funds holding SMTI

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon's SMTI Position: Q4 2025 in Review

Bank of New York Mellon sold out of Sanara MedTech (SMTI) in Q4 2025, closing a stake of 13,038 shares — an estimated $414K sold.

Bank of New York Mellon first reported a position in SMTI in Q2 2023 and held it in 10 quarters. The position peaked at $582K in Q4 2023. 53 funds tracked by Wall St. Rank hold SMTI as of Q4 2025.

Bank of New York Mellon reported no remaining Sanara MedTech position as of Q4 2025 after selling out during the quarter.
Bank of New York Mellon sold 13,038 Sanara MedTech shares in Q4 2025, an estimated $414K.
Bank of New York Mellon first reported a position in Sanara MedTech in Q2 2023 and held it in 10 quarters.
Bank of New York Mellon's Sanara MedTech position peaked at $582K in Q4 2023.
53 funds tracked by Wall St. Rank held Sanara MedTech as of Q4 2025.

Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.